Beware: Ocugen Is a Near $2 Billion Company That Has No Revenue
Beware: Ocugen Is a Near $2 Billion Company That Has No Revenue InvestorPlace 2/20/2021 © Source: Shutterstock Image of two scientists in lab coats studying results in a lab With so much intense interest in finding the next big trade, it may come as no surprise in some circles that Ocugen (NASDAQ: OCGN) has been one of the most staggeringly robust winners in memory. Since Dec. 21 of last year, OCGN stock has gained over 3,400%. Indeed, it wasn’t too long ago that shares were trading for mere pennies. © Provided by InvestorPlace Image of two scientists in lab coats studying results ...